Organisms harboring multiresistance plasmids have become a major cause of patient morbidity and mortality in hospitals since the use of antibiotics was begun (8, 25, 33) . The properties of plasmids and mechanisms of transfer between organisms have been well described (6, 17) . However, it has not been established whether these plasmids evolve in the hospital or are introduced, or what factors lead to the persistance of some plasmids once established in the environment.
These plasmids, which often carry genes for resistance to many unrelated antibiotics, have various structures and have arisen in response to a number of selective environmental effects, including the patient population, the procedures and instruments used in patient care, antibiotic usage patterns, the location of the hospital, cross-infection between patients and staff, and the properties of the individual plasmids and the bacteria that harbor them (33) . It has been shown that conjugative plasmids bearing no resistance markers but belonging to present-day incompatibility groups existed before the advent of antibiotics (12) . It therefore seems that the emergence of new resistance plasmids is the result of the insertion of new genes, probably on transposons, into existing plasmids (37) .
A study of the epidemiology of resistance genes by using specific resistance gene probes could answer questions about the origins and evolution of multiresistance in the hospital environment. In this paper we describe the construction and characterization of a gentamicin resistance (Gmr) gene probe which can be used to identify homologous genes in clinical isolates by colony and Southern hybridization techniques.
MATERIALS AND METHODS
Bacterial strains. Clinical isolates were obtained from patients at Royal North Shore Hospital of Sydney, Sydney, * Corresponding author.
Australia. Susceptibilities to antibiotics were determined by agar dilution (43) , and identification of the organisms was carried out by a replica plating method for biochemical analysis (28) . Standard strains and plasmids are listed in Table 1 . Other isolates used were from clinical specimens.
Antibiotics. Antibiotics were obtained from the following sources: amikacin, Bristol Myers; ampicillin, Commonwealth Serum Laboratories; chloramphenicol, ParkeDavis; gentamicin, Essex Laboratories; kanamycin, Bristol Myers; neomycin, Takeda Chemical Industries; rifampin, Ciba-Geigy; streptomycin, Glaxo; sulfamethoxazole, Wellcome Australia; tetracycline, Upjohn Pharmaceuticals; tobramycin, Lilly Industries Pty. Ltd.; and trimethoprim, Wellcome Australia.
Incompatibility grouping. Incompatibility grouping was carried out as described by Datta (10) .
Plasmid selected for construction of the probe. A plasmid (IncC) belonging to incompatibility group' C in a clinical isolate of Escherichia coli, VA292, was selected for the construction of the probe. IncC is common among multiresistance plasmids in clinical isolates at Royal North Shore Hospital. The MIC of gentamicin for organisms containing this group of plasmids was always greater than 5 ,ug/ml and in many instances was greater than 20 t±g/ml. E. coli VA292 was resistant to ampicillin (MIC, >100 ,ug/ml), chloramphenicol (MIC, >8 p.g/ml), gentamicin (MIC, >5 ,ug/ml), kanamycin (MIC, >20 ,ug/ml), neomycin (MIC, >20 pug/ml), sulfamethoxazole (MIC, >200 ,ug/ml), tobramycin (MIC, >5 ,ug/ml), and trimethoprim (MIC, >20 p.g/ml). (31) . Restriction fragments were resolved in 0.5, 0.8, or 2.5% agarose run at 7 V/cm for about 1 h. In all cases the running buffer was 40 mM Tris base-2 mM EDTA adjusted to pH 7.9 with acetic acid. Gels were stained for 20 mnin in 1 jig of ethidium bromide per ml before visualization at 302 nm with a transilluminator (model 302, Spectroline TR). Gels were then photographed through a no. 9 Wratten filter (Eastman Kodak Co.) with a Polaroid MP-4 camera and Polaroid type 665 film. Fragments were extracted from gels by electrophoresis onto a dialysis membrane (31) .
Ligation. Ligation of insert DNA to pBR322 was carried out by using T4 DNA ligase under standard conditions (31) .
The concentration of vector and insert DNA was determined by the criteria of Dugaiczyk et al. (15) . Subclones were generated by digestion with various restriction enzymes followed by ligation in the presence of vector DNA under similar conditions. Transformation and selection of clones. Ligated DNA was transformed into E. coli RR1 by standard methods (4). A 2-ml sample of transformants in recovery medium was suspended in 20 ml of 0.4% SeaPlaque agar (FMC Corp.) in LB broth kept liquid at 37°C. Transformants were selected on media containing 2 jig of gentamicin per ml, 20 jig of kanamycin per ml, 200 jig of sulfamethoxazole per ml, or 20 jig of trimethoprim per ml after overlaying the plates with 1 ml of the transformed bacterial suspension per plate, cooling the plates to solidify the agar, and then incubating them at 37°C overnight. Clones from the antibiotic plates were subcultured to microtiter walls containing 150 jil of LB broth, then replicated onto selective plates, and incubated at 37°C overnight.
Restriction mapping. Plasmid DNA from the subclones was isolated from an amplified culture (31) and precipitated with polyethylene glycol 6000 (24) . The DNA was digested with a number of restriction endonucleases, and the fragments were analyzed by gel electrophoresis as described above. For multiple restriction digestions with different buffer requirements, the DNA was precipitated with ethanol and redissolved before digestion with the second enzyme.
Nick translation. Nick translation of the probe was carried out by standard methods (31) . The nick-translated DNA was separated from the unreacted nucleotides by passing the reaction mixture over a Sephadex G-50 column and collecting the first radioactive peak.
Southern blot hybridization. Southern blot hybridizations were carried out on GeneScreen (New England Nuclear Corp.) as specified by the manufacturer, except for the washing procedure. For the first wash the hybridization bag was opened, the probe and the hybridization mixture were discarded, and 20 to 30 ml of 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS was added. The bag was resealed and incubated at 42°C for 10 to 15 min. Total aminoglycoside modification with ATP as cofactor was measured by bioassay (7).
RESULTS
Recombinant clones. A recombinant clone, pDGO101, selected on 2 ,ug of gentamicin per ml, contained a 7.7-kilobase (kb) BamHI fragment carrying Kmr, Gmr, Tmr, Sur, and Tpr resistance genes (Fig. 1) . A restriction map of the recombinant plasmid was generated by digestion of the DNA with combinations of the restriction enzymes BamHI, EcoRI, HindIII, PstI, and PvuI (Fig. 2) . The insertion of the fragment into the BamHI site inactivated the Tcr gene of pBR322 but left the Apr gene functional. In subclones in which the Apr gene was cut, e.g., pDGO111 (which comprises the 3.6-and 3.9-kb PvuI fragments of pDGO101 [ Fig.  2] ) and pDGO112 (which comprises the 4.6-, 1.0-, and 0.7-kb PvuI fragments of pDGO103 [ Fig. 3]) , no ampicillin resistance was expressed. These two clones contain separate pieces of insert DNA that span the entire 7.7-kb BamHI fragment. In addition to this, a Sur gene has been mapped which spans the PvuI site separating the 0.7-and 3.6-kb fragments (Fig. 2) . This led us to conclude that a functional Apr gene from E. coli E292 was absent in the cloned fragment. Plasmid DNA from pDGO101 and pDGO103 was used to derive all of the subclones listed in Table 1 .
The following subclones were selected for their suitability as Gmr probes; pDGO103 (Apr Kmr Gmr Tmr Sur) and pDGO109 (Apr Kmr Gmr Tm'), which were BamHI-EcoRI and HindIll subclones of pDGO101, respectively; and pDGO112 (Kmr Gmr Tmr), pDGO113 (Apr Kmr Gmr T9r), and pDGO114 (Kmr Gmr Tmr), which were PvuI subclones of pDGO103. A restriction map of these selected subclones (Fig. 3) shows that pDGO112, pDGO113, and pDGO114 had a 4.6-and a 1.0-kb PvuI fragment in common. The 1.0-kb PvuI fragment overlaps the 2.4-kb HindIII fragment of pDGO109, which carries the Kmr, Gmr, and Tmr gene. This gene does not have BamHI, EcoRI, HindIII, or PstI sites but may contain a PvuI site, since we have not obtained any subclones in which the 1.0-kb PvuI fragment was separated from the 4.6-kb PvuI fragment (Fig. 3) .
Tetracycline resistance is expressed in the clone pDGO106; this may be due to the 2.4-kb HindIII fragment's carrying a promoter which allows expression of the otherwise nonfunctional Tcr gene from pBR322 (44 acetyltransferases, and phosphotransferases, have different substrate profiles (14) . All the clones that conferred resistance to gentamicin also conferred resistance to kanamycin and tobramycin but were susceptible to neomycin, indicating that they did not contain a functional phosphotransferase gene [APH(3')]. On the basis of this resistance profile, it appeared that the enzyme was a 2"-O-adenylyltransferase [AAD(2")] (14, 21) . This was tested and confirmed by assaying aminoglycoside-modifying enzymes ( Table 2 ). The substrate affinity of the enzyme for gentamicin, kanamycin, and tobramycin was approximately the same. There was no affinity for amikacin and no detectable acetyltransferase activity.
The clinical isolate E. coli VA292 and its transconjugant E. coli E292 were resistant to neomycin and were shown by bioassay (7) and the disk method (42) to contain a phosphotransferase. When total adenylyltransferase and phosphotransferase activity in pDGO114 was measured by bioassay, there was no increased inactivation of kanamycin or any inactivation of neomycin, confirming that there was no phosphotransferase activity.
Southern blot and colony hybridizations. The 2.4-kb Hindlll fragment from pDGO109 and the 1.0-kb PvuI fragment from pDGO114 were isolated by gel electrophoresis and nick translated for use as probes. Southern blotting hybridizations showed that both fragments hybridized successfully to the plasmid band of the Gmr subclones (data not shown). However, the 1.0-kb fragment also hybridized with subclones that did not contain the Gmr gene but conferred resistance to sulfamethoxazole. This indicated that the 1.0-kb fragment overlapped the Sur gene, which maps adjacent to the Gmr gene. The 2.4-kb HindIII fragment did not hybridize with subclones that contained Sur genes but no Gmr gene. Additional hybridization only occurred with the DNA from pBR322. This fragment appeared to be the most suitable for developing a probe.
The 2.4-kb fragment was further trimmed with BamHI to yield a 2.0-kb fragment which did not contain any of the pBR322 DNA to test for homology with the other subclones by colony hybridization. For convenience in isolating the 2.0-kb BamHI-HindIII fragment, pDGO103 was used (BamHI-HindIII digestion of pDGO109 yields two similarsized fragments). Strong hybridization was observed specifically with all Gmr subclones.
For colony hybridization on Whatman no. 541 filter paper, the time of incubation of the plates was important for obtaining specific hybridization. Growth for 6 h at 37°C gave the best results. Longer incubation times gave increasing nonspecific hybridization due to excessive bacterial debris left on the filters, and shorter incubation times resulted in low levels of DNA on the filters and poor hybridization. Figure 4 shows the results obtained by using the 2.0-kb BamHI-HindIII probe against a set of clones, clinical isolates, and strains containing reference plasmids. There was strong hybridization with clones that contained known homologous genes, including the original clinical isolate E. coli VOL. 28, 1985 on July 8, 2017 by guest http://aac.asm.org/ 100 GROOT OBBINK ET AL. VA292 and its transconjugant E. coli E292. There was no hybridization with E. coli RR1, the host for the clones, E. coli JP995, which contained no plasmid, or with organisms containing reference plasmids R391 (IncJ), R478 (IncH), and R40a (IncC), which all contained the APH(3') gene. There was hybridization with two of the clinical isolates that were classified as IncC (E. coli VA272, VA279) and shown to contain AAD(2") _by the disk method. In separate experiments, clinical isolates that contained the acetyltransferase gene [AAC(3)-1] or APH(3')-1 were shown not to hybridize.
In Southern hybridizations, the 2.0-kb fragment hybridized with the conjugative plasmid in E. coli VA292 and its transconjugant E. coli E292. There was also hybridization in E. coli VA292 with a band corresponding to the chromosome (Fig. 5) . In other clinical isolates, hybridization commonly occurred with more than one plasmid band, including lowermolecular-weight, nonconjugative plasmids. This suggested that the ADD(2") gene may be on a mobile genetic element.
Weak hybridization was shown to occur with the plasmid band of Klebsiella pneumoniae VA273, one of the IncC clinical isolates shown to contain AAD(2") that did not hybridize on colony hybridization. No hybridizations occurred with reference plasmid R478 containing the gene for APH(3')-I.
DISCUSSION
Specific DNA probes are a convenient way of detecting homologous genes and have a wide range of applications (2, 18, 27, 34, 40) . In this paper we have described and characterized an AAD(2") probe that can be used in epidemiological studies with Southern and colony hybridization techniques.
Previously, studies of plasmid epidemiology have been difficult because selective pressures in the clinical environment cause plasmids to undergo rapid structural changes (38, 39) . When these changes are small, as may happen during an outbreak of disease caused by multiresistant organisms in hospitals, the endonuclease restriction profiles of isolated plasmids may be similar, showing that the same plasmid is involved in the epidemic (13, 41) . However, high degrees of DNA homology, possibly corresponding to resistance determinants, have been shown on plasmids which seem to be otherwise unrelated epidemiologically (32, 39) . The demonstration of different plasmid restriction endonuclease patterns does not therefore preclude homology. Whole clinical plasmids are too large and contain too much diverse genetic material to be useful as probes.
In our studies the 2-kb probe hybridized only with organisms containing the AAD(2") gene. No hybridization occurred with organisms containing AAC(3)-1 or APH(3')-1 genes but not AAD(2"). A colony hybridization technique was used in this study, as a large number of isolates can be processed at one time (22) . The use of Whatman filter papers as the support membrane is inexpensive, and the filters can be stripped of the probe and reused many times (30) . So far, no false-positives have been shown to occur and hybridization has been confirmed in Southern hybridizations. However, false-negatives occur, as shown by K. pneumoniae VA273 and Enterobacter aerogenes VA274, which were negative in colony hybridization (Fig. 4) but positive in Southern hybridizations (Fig. 5) . This may be due to the low copy number of large plasmids in some clinical isolates.
There is evidence that the AAD(2") gene probe described in this paper is part of a transposon, since hybridization of the probe was also shown to occur with nonconjugative isolates (e.g., E. coli VA292, Fig. 5 ). This has been shown to occur with other transposons (16, 29) . E. coli VA292 was isolated during an epidemic of gentamicin-resistant gramnegative rods in this hospital, and this is consistent with the concept of transposition of an AAD(2") to a common conjugative plasmid, in this case to an IncC plasmid. Transposon Tn732, which also codes for an AAD(2"), was responsible for the spread of gentamicin resistance in Toronto hospitals (35) . The movement of such resistance genes can only be followed by the use of specific probes, since small changes in plasmid size cannot be detected by gel electrophoresis. A changing restriction pattern is meaningless as far as identifying specific genes is concerned.
No sequencing data are available on the AAD(2") gene, but the genes which code for the phosphotransferase enzymes APH(3')-I and APH(3')-II and the acetyltransferase gene AAC(3)-IV have been sequenced, and their average size is approximately 800 bases (3, 5, 36) . The AAD(2") gene is about the same size (40) . The 2-kb AAD(2") probe de- scribed in this paper thus includes additional DNA sequences that are not part of the structural gene.
The AAD(2") enzyme in crude extracts of the subclone pDG0114 did not modify amikacin. On the basis of this substrate profile, the enzyme should be classified as AAD(2")-I. However, it did not completely rule out the possibility that the gene coded for AAD(2")-II, since the substrate affinity data for AAD(2")-II was determined with a highly purified enzyme preparation (7) . An association of the AAD(2") gene with IncC (as we have found) and IncFII plasmids has been previously reported (11) . This differs from another AAD(2") gene probe (40) , which originated from a plasmid not able to be classified by incompatibility group (F. C. Tenover, personal communication).
Earlier studies on a collection of gentamicin-resistant enterobacteria from this hospital and other hospitals in Australia have been limited to descriptions of the patterns of different resistance genes that are transferred by conjugation and have not differentiated between genes that confer resistance to the same antibiotic (1) . These studies could not include resistance genes found on nonconjugative plasmids or on the chromosome. The AAD(2") probe we have constructed will allow us to make a detailed study of the distribution and mobility of this gene in clinical isolates regardless of the location of the gene. The construction of further probes will allow us to make a detailed assessment of the epidemiology of antibiotic resistance in hospitals. 
